Keywords: sanofi, pasteur, dengue, vacc, enters, clinical, development

Sanofi Pasteur's dengue vacc enters clinical development

Article | 23 February 2009

Sanofi Pasteur, the vaccines division of French drug major Sanofi-Aventis, says that its investigational tetravalent Dengue vaccine is entering into ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Aventis

Aventis Pharma

Sanofi-Aventis

Go to company listing